Clinical Trial Update: HYPONCO - Hypoxia in Brain Tumors [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 trial (HYPONCO) investigating hypoxia in brain tumors in patients with anaplastic glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Glioma

Snippet

Sponsor: University Hospital, Caen | Conditions: Anaplastic Glioma | Phase 2 | Status: COMPLETED